slides · global inventory
Show Traction
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 11,828
Current window 6,661-6,690
Pages 395
Rows per page 30
Slide function
6,661-6,690 of 11,828
45
The slide uses a comparative bar chart structure to validate the efficacy of genetic companion diagnostics (CDx) in improving clinical outcomes.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
56
The slide uses a scatter plot to show correlation between Cyno and Human half-lives, and bar charts to compare ADA (Anti-Drug Antibody) rates.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
24
The slide features a split-screen layout with a metric on the left and a person speaking on the right.arm | IPO Presentation Deck | 117 slides · Arm
Pitch deck Investment bank Beat · Solution1 hit
37
The slide uses a split-screen layout with a large metric on the left and a person (likely a CEO or executive) on the right.arm | IPO Presentation Deck | 117 slides · Arm
Pitch deck Investment bank Beat · Market Size1 hit
43
The slide uses a dark, atmospheric background image of a person using a smartphone to emphasize the ubiquity of the technology.arm | IPO Presentation Deck | 117 slides · Arm
Pitch deck Investment bank Beat · Market SizeLoop · Cost Of Inaction1 hit
81
The background is a blurred image of code, suggesting a technical or developer-focused product.arm | IPO Presentation Deck | 117 slides · Arm
Pitch deck Investment bank 1 hit
104
arm | IPO Presentation Deck | 117 slidesarm | IPO Presentation Deck | 117 slides · Arm
Pitch deck Investment bank 1 hit
105
The chart highlights the long-term nature of royalty revenue, with a specific callout for products launched in the early 1990s.arm | IPO Presentation Deck | 117 slides · Arm
Pitch deck Investment bank 1 hit
04
The slide uses a grid of callout boxes to present high-level KPIs.Freightos | Investor Presentation Deck | 33 slides · Freightos
Pitch deck Investor relations 1 hit
15
Freightos | Investor Presentation Deck | 33 slidesFreightos | Investor Presentation Deck | 33 slides · Freightos
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
16
The chart illustrates cohort expansion (net dollar retention/transaction growth) over time.Freightos | Investor Presentation Deck | 33 slides · Freightos
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
17
The chart uses a trend line to emphasize the exponential growth trajectory.Freightos | Investor Presentation Deck | 33 slides · Freightos
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
19
The slide uses the term 'flywheel' in the title, though the content is a data table rather than a diagram.Freightos | Investor Presentation Deck | 33 slides · Freightos
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
04
Genius Group | Investor Presentation Deck | 29 slidesGenius Group | Investor Presentation Deck | 29 slides · Genius Group
Pitch deck Investor relations 1 hit
08
The 'Total Student Numbers' axis unit is likely in millions, though not explicitly labeled as such.Genius Group | Investor Presentation Deck | 29 slides · Genius Group
Pitch deck Investor relations 1 hit
24
Genius Group | Investor Presentation Deck | 29 slidesGenius Group | Investor Presentation Deck | 29 slides · Genius Group
Pitch deck Investor relations Beat · Financials1 hit
25
Genius Group | Investor Presentation Deck | 29 slidesGenius Group | Investor Presentation Deck | 29 slides · Genius Group
Pitch deck Investor relations Beat · Financials1 hit
12
The slide uses a list of specific study examples to build credibility.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations Beat · Traction1 hit
13
The slide highlights regulatory milestones as a proxy for product validation and market readiness.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations Beat · Traction1 hit
15
The slide uses a diagonal timeline layout to represent product evolution.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations Beat · Traction1 hit
16
The 2023 figure is marked with an asterisk indicating revenue guidance.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations Beat · Traction1 hit
17
The chart shows a progression from negative margin to positive margin.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations Beat · Traction1 hit
18
The slide uses a bar chart to demonstrate financial discipline and outlines three key areas of investment.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations Beat · Traction1 hit
11
The chart demonstrates the efficacy of NXC-201 (formerly HBI0101) in clearing diseased cells.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
17
Includes detailed clinical trial citations in the footer.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
20
The table uses a standard pharmaceutical pipeline format, categorizing by clinical vs preclinical status and highlighting specific regulatory and clinical trial milestones.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
25
The chart uses a grouped bar structure to compare efficacy across patient segments (No BCMA, Yes BCMA, Overall).Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
27
The slide uses a two-column layout to compare clinical data for two different indications, supported by competitor market data.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
28
The chart illustrates deepening responses over time in a clinical trial setting.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Desire1 hit
36
Slide contains three distinct data visualizations comparing IMX-110 against standard of care or historical benchmarks.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Desire1 hit